Epilepsy Meds App Wins Silver at PM Society Digital Awards 2025

Epilepsy Meds, the clinical support app developed by Genetic Digital, Desitin Pharma, and ChangeMed, has won Silver at the 2025 PM Society Digital Awards. Recognised for its impact in HCP education, the app is now in use across NHS Trusts and endorsed by key epilepsy organisations.

Epilepsy Meds App Shortlisted for PM Society Digital Award

We’re proud to announce that our Epilepsy Meds mobile app, developed for Desitin Pharma, has been shortlisted in the PM Society Digital Awards 2025. Recognised in the HCP Education, Training & Support category, the app supports clinicians in making confident, patient-centred prescribing decisions in epilepsy care.

We’re shortlisted for a PM Society Digital Media Award!

Genetic Digital has been shortlisted as a finalist at this years PM Society’s Digital Media Awards. Their LinkedIn campaign for Britannia Pharmaceuticals has been shortlisted under the ‘Social Media’ category. Damon Lightley, MD of Genetic Digital comments: “As a young but fast growing agency, to have our work credited by a highly reputable third party […]